Comparison of EQ-5D and SF-6D utilities in Pompe disease

被引:12
|
作者
Kanters, T. A. [1 ,2 ]
Redekop, W. K. [1 ]
Kruijshaar, M. E. [2 ,3 ]
van der Ploeg, A. T. [2 ,3 ]
Rutten-van Molken, M. P. M. H. [1 ]
Hakkaart, L. [1 ]
机构
[1] Erasmus Univ, Inst Med Technol Assessment, Dept Hlth Policy & Management, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC Univ, Med Ctr, Ctr Lysosomal & Metab Dis, NL-3015 GJ Rotterdam, Netherlands
[3] Erasmus MC Univ, Med Ctr Rotterdam, Dept Pediat, Div Metab Dis & Genet, NL-3015 GJ Rotterdam, Netherlands
关键词
Preference-based measure of health; EQ-5D; SF-6D; Orphan disease; Pompe disease; HEALTH; ADULTS; INSTRUMENTS; PROGRESSION; VALIDITY; EUROQOL; IMPACT;
D O I
10.1007/s11136-014-0833-2
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Comparative studies between Euroqol-5D (EQ-5D) and ShortForm 6D (SF-6D) utilities have been performed for a number of diseases, but not yet for orphan diseases. Pompe disease is an orphan disease with a prevalence of < 5/10,000, characterized by impaired ambulatory and pulmonary functioning. We compared the psychometric properties of EQ-5D and SF-6D in patients with this disease and assessed their convergent validity, discriminative ability and sensitivity to change. EQ-5D utilities and SF-6D utilities were computed using the UK value set. Dimensions and utilities of the two instruments were compared by correlation coefficients and descriptive statistics. We assessed whether EQ-5D and SF-6D were able to discriminate between different levels of severity and examined sensitivity to change for patients with multiple observations. Correlations between theoretically related dimensions of the EQ-5D and SF-6D were highly significant and were moderate to strong (range rho = 0.409-0.564). Utility values derived from the two instruments were similar (mean EQ-5D = 0.670; mean SF-6D = 0.699) and correlated strongly (rho = 0.591). Discriminative properties were somewhat better for EQ-5D; mean changes and effect sizes were better for SF-6D. Overall, we conclude that both instruments appear to be equally appropriate with respect to assessing utilities in Pompe disease, but neither of them performed excellently. The descriptive system of the SF-6D describes health states for Pompe disease more accurately. EQ-5D showed better discriminative properties. The SF-6D performed better with respect to sensitivity to change.
引用
收藏
页码:837 / 844
页数:8
相关论文
共 50 条
  • [41] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    M. J. Harrison
    L. M. Davies
    N. J. Bansback
    M. J. McCoy
    S. M. M. Verstappen
    K. Watson
    D. P. M. Symmons
    Quality of Life Research, 2009, 18 : 1195 - 1205
  • [42] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Roisin Adams
    Cathal Walsh
    Douglas Veale
    Barry Bresnihan
    Oliver FitzGerald
    Michael Barry
    PharmacoEconomics, 2010, 28 : 477 - 487
  • [43] Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis
    Adams, Roisin
    Walsh, Cathal
    Veale, Douglas
    Bresnihan, Barry
    FitzGerald, Oliver
    Barry, Michael
    PHARMACOECONOMICS, 2010, 28 (06) : 477 - 487
  • [44] The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure
    Nick Kontodimopoulos
    Michalis Argiriou
    Nikolaos Theakos
    Dimitris Niakas
    The European Journal of Health Economics, 2011, 12 : 383 - 391
  • [45] A CALIBRATION OF THE RELATIONSHIP BETWEEN THE HAQ, THE SF-6D AND THE EQ-5D IN INFLAMMATORY ARTHRITIS
    Adams, R.
    Walsh, C.
    Tilson, L.
    FitzGerald, O.
    Bresnihan, B.
    Veale, D.
    Barry, M.
    VALUE IN HEALTH, 2009, 12 (07) : A446 - A447
  • [46] The validity of estimating EQ-5D and SF-6D utility values from the HAP
    Harrison, Mark J.
    Lunt, Mark
    Bansback, Nick
    Verstapen, Suzanne
    Watson, Kath
    Symmons, Deborah
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S204 - S204
  • [47] PREDICTING EQ-5D, SF-6D AND 15D UTILITIES FROM EORTC QLQ-C30 DATA
    Kontodimopoulos, N.
    Paliouras, D.
    Pappa, E.
    Papadopoulos, A. A.
    Aletras, V. H.
    Niakas, D.
    VALUE IN HEALTH, 2008, 11 (06) : A341 - A341
  • [48] EQ-5D versus SF-6D in an older, chronically ill patient group
    Gerard K.
    Nicholson T.
    Mullee M.
    Mehta R.
    Roderick P.
    Applied Health Economics and Health Policy, 2004, 3 (2) : 91 - 102
  • [49] The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
    Harrison, M. J.
    Davies, L. M.
    Bansback, N. J.
    McCoy, M. J.
    Verstappen, S. M. M.
    Watson, K.
    Symmons, D. P. M.
    QUALITY OF LIFE RESEARCH, 2009, 18 (09) : 1195 - 1205
  • [50] Evaluating a falls prevention intervention in older home care recipients: a comparison of SF-6D and EQ-5D
    Bjerk, Maria
    Brovold, Therese
    Davis, Jennifer C.
    Bergland, Astrid
    QUALITY OF LIFE RESEARCH, 2019, 28 (12) : 3187 - 3195